A fully operational, CLIA-certified molecular laboratory located in Dallas, TX, is available for immediate acquisition. The lab is Medicare- and Texas Medicaid-approved, with robust infrastructure and top-tier equipment investments from previous ownership — presenting a true turnkey acquisition for any group looking to expand into the Novitas MAC region.
Key Features
-CLIA-Certified – Fully compliant and meets all regulatory requirements.
-Medicare & TX Medicaid Approved – Ready to process insurance claims immediately.
Validated Testing Menu:
-Pharmacogenomics (PGx) – newly validated
-COVID-19, Influenza (Flu), Antibody (AB), and RSV panels
High-End Equipment:
-Thermo Fisher QuantStudio 12k (with AccuFill Open Array and 384-well block)
-Ensures scalability, precision, and high-throughput performance.
-Infrastructure Investment: Recently upgraded facility with premium buildout and modern workflow design.
-The laboratory has undergone significant capital investment from previous owners, ensuring high-quality facilities and equipment, making this an ideal turnkey operation for a buyer. This is an excellent opportunity for a group looking to enter the industry with a well-established laboratory or for those seeking to expand their reach with an additional location within the -Novitas Medicare MAC.
Why Buy This Laboratory:
-No Billing History – A clean slate, ideal for buyers wanting full control of revenue setup.
-Expansion Opportunity – Perfect entry or add-on for buyers targeting the Novitas Medicare MAC territory.
-Turnkey Readiness – Fully operational lab with certifications, equipment, and infrastructure in place.
-Attractive Price Point – Professionally validated, equipped, and certified for under $1M.
Summary
This lab is positioned as a ready-to-operate PGx and molecular diagnostics facility with all key compliance and payer approvals secured. Whether you’re expanding an existing lab network or entering the diagnostics sector, this asset offers immediate operational capability in a desirable market.
